{
    "Trade/Device Name(s)": [
        "Plexus HerpeSelect 1 and 2 IgG",
        "HerpeSelect 1 and 2 Plexus IgG"
    ],
    "Submitter Information": "Focus Diagnostics, Inc.",
    "510(k) Number": "K062543",
    "Predicate Device Reference 510(k) Number(s)": [
        "HerpeSelect 1 and 2 Immunoblot IgG",
        "HerpeSelect-1 ELISA IgG",
        "HerpeSelect-2 ELISA IgG"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ",
        "MYF"
    ],
    "Summary Letter Date": "January 15, 2007",
    "Summary Letter Received Date": "January 17, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological reagents"
    ],
    "Analyte Class(es)": [
        "serology",
        "virology"
    ],
    "Analyte(s)": [
        "HSV-1 IgG",
        "HSV-2 IgG"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Multiplexed immunoassay"
    ],
    "Methodologies": [
        "Serological testing"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Focus Diagnostics Plexus HerpeSelect 1 and 2 IgG multiplexed immunoassay for detection of HSV-1 and HSV-2 IgG in human serum",
    "Indications for Use Summary": "Qualitative detection of human IgG class antibodies to HSV-1 and HSV-2 in serum to aid presumptive diagnosis in sexually active adults or expectant mothers; not established for pediatric, neonatal, immunocompromised, point-of-care, or automated use",
    "fda_folder": "Microbiology"
}